-
-
-
-
-
-
-
H.C. Wainwright Starts Q32 Bio Inc. (QTTB) at Buy
-
-
-
-
-
-
-
Q32 Bio (QTTB) Misses Q1 EPS by 90c
-
-
-
-
-
-
-
Q32 Bio (QTTB) Announces Strategic Restructuring to Focus on Advancement of Bempikibart in Patients with Alopecia Areata
-
-
-
-
-
-
-
After-hours movers: GM, Stitch Fix, Dave & Buster's, GME and more
-
-
-
-
-
-
-
Q32 Bio (QTTB) Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis
-
416,806 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

